- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05004857
The Effect of Reading Therapy on Newborns
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Supporting infant ANS development has been implicated in their improved cardiorespiratory and neuropsychiatric outcome; furthermore, improved parasympathetic activity, a branch of ANS, is a predictor of the mother-infant relationship, and the best marker for caregiving behavior. In Feldman and Eidelman's 2003 study, they demonstrated that mother-infant skin-to-skin contact, also known as Kangaroo Care, accelerates ANS maturation in pre-term infants, which is critical for their recovery. If reading is shown to have a positive effect on mother infant ANS, hospitals will be able to incorporate this into practice as a feasible alternative for when Kangaroo Care isn't possible. The investigators hope to learn if these reading interventions will help to mitigate distress symptoms, among both mother and baby, within the hospital. The investigators will examine the association of reading therapy with the infant's crying patterns, length of stay in the hospital, weight gain, and behavior compared to before the reading was done.
Seeing that Scala's findings from 2018 is the only indication of physiologic benefits of reading to infants in the hospital, additional research is required in this particular area. The testing and application of reading therapy in the Neonatal Intensive Care Unit (NICU) would improve a high-stress environment for both parents and infants. Data collected from this project will not only add some much-needed information to the limited knowledge of the physiological effects of reading on neonates, but also demonstrate how infant outcomes can be improved in a cost-effective, efficient manner within the hospital setting.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Meghan Howell, MD, MS
- Phone Number: 504-428-9201
- Email: mhowell2@tulane.edu
Study Contact Backup
- Name: Asha Dash, BS
- Phone Number: 504-228-9433
- Email: adash1@tulane.edu
Study Locations
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Recruiting
- Tulane University Health Sciences Center
-
Contact:
- Meghan Howell, MD, MS
- Phone Number: 504-428-9201
- Email: mhowell2@tulane.edu
-
Contact:
- Asha Dash, BS
- Phone Number: 504-228-9433
- Email: adash1@tulane.edu
-
Principal Investigator:
- Meghan Howell, MD, MS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admitted to the Tulane-Lakeside Hospital Newborn Nursery
- Corrected gestational age 34 weeks or older
- No identified hearing disorder
- Do not have a diagnosed developmental disability (i.e. Down Syndrome)
- Do not have Fetal Alcohol Syndrome
- Medically cleared to participate in the study
- Biological mother able/willing to give consent in English & complete surveys.
Exclusion Criteria:
- Corrected gestational age < 34 weeks old
- Has an identified or potential hearing disorder (i.e, failed hearing screen)
- Has diagnosed developmental disability (i.e. Down syndrome)
- Has Fetal Alcohol Syndrome
- Is not medically cleared to participate in the study
- Biological mother unable/unwilling to give consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patient arm
The subject population will be newborn infants admitted to the Newborn Nursery (NN) at Tulane Lakeside Hospital.
The investigators are anticipating some mothers can be recruited from the prenatal clinics who expect to deliver at Tulane Hospital during pregnancy as well.
|
Prior to the first session, a research assistant will place electrodes on the infant and mother so that they study team can gather autonomic nervous system (ANS) response (sympathetic and parasympathetic) non-invasively using MindWare Portable Lab System (MindWare Technologies, Gahanna, Ohio).
These electrodes will remain on the infant and mother throughout each session and be removed via adhesive removing pads following each session's data collection.
This will minimize discomfort to both parties secondary to electrode removal and minimize risk of skin irritation by leaving electrodes in place for a prolonged period of time.
Additional observational data before and after the reading sessions will be collected by the research assistant, including but not limited to: where the session is conducted (mother's arms, bassinet), activity level, vital signs, and any other observed behaviors throughout the session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determine the change in vagal tone
Time Frame: 20 minutes of reading
|
The change in vagal tone from the reading therapy will be measured using MindWare System, where an increase in vagal tone shows positive physiological outcomes in the newborns and mothers.
|
20 minutes of reading
|
Determine the change in parasympathetic nervous system response
Time Frame: 20 minutes of reading
|
The change in parasympathetic nervous system response from the reading therapy will be measured using MindWare System, where an increase in parasympathetic nervous system response shows positive physiological outcomes in the newborns and mothers.
|
20 minutes of reading
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Meghan Howell, MD, MS, Tulane University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-611
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autonomic Nervous System Diseases
-
The Hong Kong Polytechnic UniversityUnknownAutonomic Nervous System DisorderChina
-
Northwell HealthEnrolling by invitationAutonomic Nervous System Diseases | Autonomic Dysfunction | Autonomic Imbalance | Vagus Nerve Autonomic DisorderUnited States
-
Istanbul Medipol University HospitalCompletedVagus Nerve Autonomic DisorderTurkey
-
Virginia Polytechnic Institute and State UniversityNot yet recruiting
-
University of Mississippi Medical CenterVicor Technologies, Inc.CompletedAutonomic DysfunctionUnited States
-
Federal University of Health Science of Porto AlegreCompletedVertebra; Degeneration | Other Disorders of the Autonomic Nervous SystemBrazil
-
National Institute of Neurological Disorders and...Completed
-
Fondazione Don Carlo Gnocchi OnlusCompletedAutonomic Nervous System Disease | Osteopathy
-
University of MichiganCompletedAutonomic Peripheral Nervous System DiseasesUnited States
-
University College, LondonNational Institutes of Health (NIH)Not yet recruitingEpilepsy | Vagus Nerve Diseases | Vagus Nerve Autonomic Disorder
Clinical Trials on Book reading
-
University of KansasNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedSpecific Language ImpairmentUnited States
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingShared Book Reading With Specifically Named Characters v. Generically Named Characters v. no Book ControlUnited States
-
University of KansasNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingLanguage Development DisordersUnited States
-
University of DaytonCompleted
-
Universidad de Costa RicaCaja Costarricense de Seguro SocialCompletedLanguage DevelopmentCosta Rica
-
National University of Ireland, Galway, IrelandHealth Research Board, IrelandUnknown
-
Beth Israel Deaconess Medical CenterCompletedCovid19 | Stress | Anxiety DepressionUnited States
-
University of SheffieldCompleted
-
Beth Israel Deaconess Medical CenterCompletedStress | Burnout | Depression, AnxietyUnited States
-
China Medical University HospitalRecruitingAcupuncture LearningTaiwan